ACIDE ZOLEDRONIQUE TILLOMED 4 mg/5 ml, concentrate for solution for infusion bottle, 5 ml
Active ingredients: Anhydrous zoledronic acid, Zoledronic acid monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusionbottle, 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACIDE ZOLEDRONIQUE TILLOMED 4 mg/5 mL, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 5 ml
- Marketing authorisation holder
- TILLOMED PHARMA (ALLEMAGNE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Jun 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69694737CIP73021745CIP133400930217450Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE ZOLÉDRONIQUE ANHYDREsolution | 4 mg · 5 mL de solution à diluer | FT |
| ACIDE ZOLÉDRONIQUE MONOHYDRATÉsolution | 4,264 mg · 5 mL de solution à diluer | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.